Next Generation
in Protein

RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality.

The Journal Of Pharmaceutical Sciences magazine cover

The Journal of Pharmaceutical Sciences published a paper authored by a team at Pfizer featuring the AQS3pro

The Next Generation in Protein Characterization

The AQS3pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. The AQS3pro generates repeatable, automated measurements with high sensitivity in complex formulation conditions that are not possible with traditional analytical methods.


Investigate change and download our latest literature


Join us for our monthly webinars introducing microfluidic modulation spectroscopy